Inhibition of growth of androgen-independent DU-145 prostate cancer in vivo by luteinising hormone-releasing hormone antagonist Cetrorelix and bombesin antagonists RC-3940-II and RC-3950-II.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples